Health Catalyst (HCAT) Liabilities and Shareholders Equity (2018 - 2026)

Health Catalyst's Liabilities and Shareholders Equity history runs 9 years deep, the most recent figure standing at $412.2 million for Q1 2026.

• Quarterly Liabilities and Shareholders Equity fell 53.77% year-over-year to $412.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.1 billion (down 34.93% YoY) and the FY2025 annual result came in at $502.6 million, down 41.48% from the prior year.
• Liabilities and Shareholders Equity was $412.2 million for Q1 2026 at Health Catalyst, down from $502.6 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $891.5 million in Q1 2025 and bottomed at $412.2 million in Q1 2026.
• A 5-year average of $713.1 million and a median of $722.9 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
• Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity jumped 44.41% — and 2026, when it slumped 53.77%.
• Health Catalyst's Liabilities and Shareholders Equity stood at $752.3 million in 2022, then retreated by 6.71% to $701.8 million in 2023, then grew by 22.39% to $858.9 million in 2024, then slumped by 41.48% to $502.6 million in 2025, then slipped by 17.99% to $412.2 million in 2026.
• Business Quant data shows HCAT's Liabilities and Shareholders Equity at $412.2 million in Q1 2026, $502.6 million in Q4 2025, and $587.1 million in Q3 2025.